腾药Tengyao品牌怎么样 申请店铺

我要投票 腾药Tengyao在乌鸡白凤丸行业中的票数:131 更新时间:2024-12-26
腾药Tengyao是哪个国家的品牌?「腾药Tengyao」是 云南腾药制药股份有限公司 旗下著名品牌。该品牌发源于云南省保山市,由创始人赵丙贤在1990-06-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
腾药Tengyao怎么样

云南腾药制药股份有限公司(以下简称“腾药”)成立于1956年,1997年改为股份合作制企业,2011年9月在县委政府的关心支持下完成股份制改造,同年11月与北京中证万融医药投资集团实现战略合作。

历经五十多年历史积淀的腾药,目前在编在岗员工600余人(含销售人员),具备了雄厚的制药技术基础,公司在不断汲取现代科学技术的基础上具备了专业的检测手段。两者的有机结合,使“腾药”产品有了过硬的质量,造就的品种有心脉隆注射液、安宫牛黄丸、人参再造丸、六味地黄丸、六灵丸、藿香正气水、感冒疏风片、清肺抑火片等。年生产规模为2000多吨,主要剂型有注射剂、丸剂(大蜜丸、小蜜丸、水丸、水蜜丸)、片剂、颗粒剂、散剂、酒剂、酊剂、糖浆剂,国药准字批文 130个,87个品种,137个品规,均是中药、天然药物。其中,国家二类新药“心脉隆注射液”由企业与大理学院联合研制,于2007年获准生产上市,为腾药的发展注入了新的活力。

规划:发展为以心脉隆注射液为主,传统普药为辅,日化保健品为补的上市企业。

党建:公司党总支下设5个党支部,共有党员62名(其中女党员37名)。

文化:公司起源于药王宫(建于明代天启六年)——全国中医药文化宣传教育基地,整个以求健康、传健康、学健康、食健康为主。公司秉承诚信制药,争做百年腾药。公司核心使命:“为人类健康创造卓越价值”,核心价值:“顾客第一服务他人 诚信 创新”。

诚信:公司一直秉承诚信制药的优良传承,用“宁为上药三分利,莫负良医九折肱”的对联警醒着一代又一代制药人。

创新:以心脉隆注射液为主的科研课题研究、美蠊系列日化保健品开发。


Yunnan tengyao Pharmaceutical Co., Ltd. (hereinafter referred to as "tengyao") was founded in 1956, changed into a joint-stock cooperative enterprise in 1997, completed the joint-stock transformation in September 2011 with the care and support of the county Party committee and government, and achieved strategic cooperation with Beijing Zhongzheng Wanrong pharmaceutical investment group in November of the same year. After more than 50 years of historical accumulation, tengyao has more than 600 employees (including sales staff) on the job at present, with a strong pharmaceutical technology foundation, and the company has a professional testing method based on continuous learning of modern science and technology. The organic combination of the two makes the "tengyao" products have excellent quality. The varieties created are Xinmailong injection, Angongniuhuang pill, Renshen Zaizai pill, Liuwei Dihuang pill, Liuling pill, Huoxiang Zhengqi water, Ganmao Shufeng tablet, Qingfei Yihuo tablet, etc. The annual production scale is more than 2000 tons, and the main dosage forms are injection, pill (big honey pill, small honey pill, water pill, water honey pill), tablet, granule, powder, liquor, tincture, syrup. There are 130 national drug approval documents, 87 varieties, 137 product specifications, all of which are traditional Chinese medicine and natural medicine. Among them, Xinmailong injection, a national second-class new drug, was jointly developed by the enterprise and Dali University, and was approved for production and listing in 2007, which injected new vitality into the development of tengyao. Planning: to develop into a listed enterprise mainly with Xinmailong injection, supplemented by traditional general medicine and supplemented by daily chemical health products. Party Construction: the company has 5 party branches under the general Party branch, with 62 party members (including 37 female party members). Culture: the company originated in the palace of Medicine (built in the sixth year of Tianqi in Ming Dynasty) - the national base of traditional Chinese medicine culture publicity and education, focusing on health, transmission, learning and eating. The company adheres to the integrity of pharmaceutical, striving to be a century drug. The company's core mission: "to create outstanding value for human health", and its core value: "customer first, serve others and innovate with integrity". Integrity: the company has always been adhering to the good heritage of integrity pharmaceutical, with the couplet of "better for the third profit of the drug, better for the nine fold arm" to alert generations of pharmaceutical people. Innovation: Research on Xinmailong injection as the main scientific research topic, and development of Periplaneta americana series of daily chemical health products.

本文链接: https://brand.waitui.com/19813d252.html 联系电话:08755133464

千城特选小程序码

7×24h 快讯

宝光股份:拟4200万元收购股权及增资取得凯赛尔科技51.16%股权

36氪获悉,宝光股份公告,公司与成都凯赛尔贸易有限公司、成都凯赛尔科技有限公司(简称“凯赛尔科技”)拟签订股权转让与增资扩股协议,公司拟通过收购股权及增资方式,以4200万元获得凯赛尔科技51.16%股权,本次交易完成后,凯赛尔科技将成为公司的控股子公司。凯赛尔科技主要从事真空灭弧室(固封极柱)的设计、研发、生产、加工及销售。

31分钟前

6连板实益达:目前不涉及“微信小店”的业务

36氪获悉,实益达公告,公司发现市场对“微信小店”概念较为关注,公司(含合并报表范围内的控股公司)目前不涉及“微信小店”的业务;公司目前的主要业务及产品为:1.智能硬件制造业务:主要系公司为品牌商提供工业级设备及新能源相关产品的工程测试、制造、供应链管理等系列服务;2.智能终端产品业务:主要系LED智能照明及相关配套智能终端产品的设计、研发、生产和销售,为客户提供LED产品解决方案。

31分钟前

美股大型科技股盘前多数下跌,Arm跌超1%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,Arm跌超1%,英伟达跌0.73%,谷歌跌0.55%,Meta跌0.32%,微软跌0.3%,苹果跌0.23%;特斯拉涨0.96%。

32分钟前

热门中概股美股盘前涨跌不一,搜狐跌超4%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,理想汽车涨超4%,小鹏汽车涨0.62%,蔚来涨0.43%,阿里巴巴涨0.41%,B站涨0.36%;搜狐跌超4%,京东跌0.38%,百度跌0.34%,拼多多跌0.12%。

32分钟前

信息发展:实控人拟公开挂牌转让交信基金30%股权

36氪获悉,信息发展公告,公司获悉,公司实控人交通运输通信信息集团有限公司(简称“交通通信集团”)通过在北京产权交易所公开挂牌方式转让所持的交信(上海)私募基金管理有限公司(简称“交信基金”)30%股权,将以288.82万元公开挂牌转让,具体交易价格将按公开挂牌竞价结果确定。如本次股权转让交易完成,交通通信集团将不再持有交信基金股权。

32分钟前

本页详细列出关于中联的品牌信息,含品牌所属公司介绍,中联所处行业的品牌地位及优势。
咨询